Charles & Colvard, Ltd. Stock Forecast, Price & News

Charles & Colvard, Ltd. (NASDAQ:CTHR) Frequently Asked Questions

Is Charles & Colvard, Ltd. a buy right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Charles & Colvard, Ltd. in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Charles & Colvard, Ltd. stock.
View analyst ratings for Charles & Colvard, Ltd. or view top-rated stocks.

How has Charles & Colvard, Ltd.'s stock been impacted by COVID-19 (Coronavirus)?

Charles & Colvard, Ltd.'s stock was trading at $0.7553 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, CTHR shares have increased by 280.0% and is now trading at $2.87.
View which stocks have been most impacted by COVID-19.

Are investors shorting Charles & Colvard, Ltd.?

Charles & Colvard, Ltd. saw a decline in short interest during the month of November. As of November 15th, there was short interest totaling 131,900 shares, a decline of 19.5% from the October 31st total of 163,900 shares. Based on an average trading volume of 206,300 shares, the days-to-cover ratio is currently 0.6 days. Currently, 0.6% of the company's shares are short sold.
View Charles & Colvard, Ltd.'s Short Interest.

When is Charles & Colvard, Ltd.'s next earnings date?

Charles & Colvard, Ltd. is scheduled to release its next quarterly earnings announcement on Thursday, February 3rd 2022.
View our earnings forecast for Charles & Colvard, Ltd..

How were Charles & Colvard, Ltd.'s earnings last quarter?

Charles & Colvard, Ltd. (NASDAQ:CTHR) issued its quarterly earnings data on Thursday, November, 4th. The company reported $0.03 earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of $0.02 by $0.01. The business earned $10.28 million during the quarter, compared to analysts' expectations of $9.20 million. Charles & Colvard, Ltd. had a trailing twelve-month return on equity of 24.90% and a net margin of 30.69%. During the same quarter in the previous year, the business posted $0.03 earnings per share.
View Charles & Colvard, Ltd.'s earnings history.

What price target have analysts set for CTHR?

1 brokerages have issued twelve-month price targets for Charles & Colvard, Ltd.'s shares. Their forecasts range from $3.75 to $3.75. On average, they anticipate Charles & Colvard, Ltd.'s stock price to reach $3.75 in the next year. This suggests a possible upside of 30.7% from the stock's current price.
View analysts' price targets for Charles & Colvard, Ltd. or view top-rated stocks among Wall Street analysts.

Who are Charles & Colvard, Ltd.'s key executives?

Charles & Colvard, Ltd.'s management team includes the following people:

• Don O'Connell, President, Chief Executive Officer & Director
• Clint J. Pete, Chief Financial Officer & Treasurer

Who are some of Charles & Colvard, Ltd.'s key competitors?

Some companies that are related to Charles & Colvard, Ltd. include Barnes & Noble Education (BNED), Alto Ingredients (ALTO), American Outdoor Brands (AOUT), Vitru (VTRU), Isos Acquisition (ISOS), Full House Resorts (FLL), Hemisphere Media Group (HMTV), StoneMor (STON), Civeo (CVEO), Emerald (EEX), Hooker Furniture (HOFT), Lottery.com (LTRY), Universal Technical Institute (UTI), Kandi Technologies Group (KNDI) and Television Broadcasts (TVBCY).
View all of CTHR's competitors.

What other stocks do shareholders of Charles & Colvard, Ltd. own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Charles & Colvard, Ltd. investors own include Matinas BioPharma (MTNB), ADMA Biologics (ADMA), Golar LNG Partners (GMLP), Novan (NOVN), OrganiGram (OGI), Pennsylvania Real Estate Investment Trust (PEI), Bionano Genomics (BNGO), Gran Tierra Energy (GTE), Zosano Pharma (ZSAN) and Aeterna Zentaris (AEZS).

What is Charles & Colvard, Ltd.'s stock symbol?

Charles & Colvard, Ltd. trades on the NASDAQ under the ticker symbol "CTHR."

Who are Charles & Colvard, Ltd.'s major shareholders?

Charles & Colvard, Ltd.'s stock is owned by a variety of institutional and retail investors. Top institutional investors include Renaissance Technologies LLC (7.33%), Acuitas Investments LLC (1.23%), Geode Capital Management LLC (0.76%), Essex Investment Management Co. LLC (0.74%), Dimensional Fund Advisors LP (0.69%) and Two Sigma Advisers LP (0.67%). Company insiders that own Charles & Colvard, Ltd. stock include Clint J Pete, Don O'connell and Ollin B Sykes.
View institutional ownership trends for Charles & Colvard, Ltd..

Which major investors are selling Charles & Colvard, Ltd. stock?

CTHR stock was sold by a variety of institutional investors in the last quarter, including Millennium Management LLC, Renaissance Technologies LLC, Two Sigma Advisers LP, and Two Sigma Investments LP.
View insider buying and selling activity for Charles & Colvard, Ltd. or view top insider-selling stocks.

Which major investors are buying Charles & Colvard, Ltd. stock?

CTHR stock was bought by a variety of institutional investors in the last quarter, including Essex Investment Management Co. LLC, Acuitas Investments LLC, Dimensional Fund Advisors LP, Geode Capital Management LLC, and BlackRock Inc.. Company insiders that have bought Charles & Colvard, Ltd. stock in the last two years include Clint J Pete, Don O'connell, and Ollin B Sykes.
View insider buying and selling activity for Charles & Colvard, Ltd. or or view top insider-buying stocks.

How do I buy shares of Charles & Colvard, Ltd.?

Shares of CTHR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Charles & Colvard, Ltd.'s stock price today?

One share of CTHR stock can currently be purchased for approximately $2.87.

How much money does Charles & Colvard, Ltd. make?

Charles & Colvard, Ltd. has a market capitalization of $87.31 million and generates $39.24 million in revenue each year. The company earns $12.81 million in net income (profit) each year or $0.42 on an earnings per share basis.

How many employees does Charles & Colvard, Ltd. have?

Charles & Colvard, Ltd. employs 48 workers across the globe.

What is Charles & Colvard, Ltd.'s official website?

The official website for Charles & Colvard, Ltd. is www.charlesandcolvard.com.

Where are Charles & Colvard, Ltd.'s headquarters?

Charles & Colvard, Ltd. is headquartered at 170 SOUTHPORT DRIVE, MORRISVILLE NC, 27560.

How can I contact Charles & Colvard, Ltd.?

Charles & Colvard, Ltd.'s mailing address is 170 SOUTHPORT DRIVE, MORRISVILLE NC, 27560. The company can be reached via phone at (919) 468-0399, via email at [email protected], or via fax at 919-468-0486.